Spontaneous remission of IgA nephropathy associated with resolution of hepatitis A

Am J Kidney Dis. 2010 Dec;56(6):1163-7. doi: 10.1053/j.ajkd.2010.08.018. Epub 2010 Oct 8.

Abstract

Although most cases of immunoglobulin A (IgA) nephropathy are idiopathic, several diseases are associated with IgA nephropathy. Of these, chronic liver disease resulting from hepatitis B or C virus infection has been reported as a secondary cause of IgA nephropathy. Recently, hepatitis A virus (HAV)-associated kidney disease has received attention because acute kidney injury can occur as a complication of HAV infection, generally caused by acute tubular necrosis or interstitial nephritis. However, unlike IgA nephropathy related to hepatitis B or C, HAV-associated IgA nephropathy is extremely rare and long-term outcomes have not been reported yet. We describe a case of spontaneous remission of IgA nephropathy associated with serologically documented HAV infection. The patient presented with microhematuria and moderate proteinuria, but acute kidney injury did not occur during active hepatic injury. Kidney biopsy specimens clearly showed mesangial IgA deposits with intact tubules and interstitium. Serum liver enzyme levels returned to reference values 1 month after the onset of acute hepatitis, but urinary protein excretion remained increased. Approximately 1 year later, urinary abnormalities were resolved and a second biopsy showed no mesangial IgA deposits. These findings suggest that IgA nephropathy can transiently accompany HAV infection, but may not progress to chronic glomerulonephritis after recovery from HAV.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antiviral Agents / therapeutic use
  • Biopsy
  • Female
  • Glomerulonephritis, IGA / etiology*
  • Hepatitis A / complications*
  • Hepatitis A / drug therapy*
  • Humans
  • Immunoglobulin A / metabolism
  • Mesangial Cells / metabolism
  • Mesangial Cells / pathology
  • Remission, Spontaneous*
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Immunoglobulin A